Physician profile
Catherine Doyle
NPI 1003445081
$10,888.36
in general payments reported to CMS, 2019-2025
12 companies · $9,292 in 2025
The $9,292 reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $635 · 2023: $395 · 2024: $566 · 2025: $9,292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,675 · Grant: $3,333 · Travel and Lodging: $3,202 · Education: $42.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,675.04 |
| Grant | $3,333.33 |
| Travel and Lodging | $3,202.23 |
| Education | $42.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,631.70 | 2025 | Evos, Trigen, Evos Mini |
| Stryker Corporation | $3,322.03 | 2022-2025 | Pro, Gamma, Pangea |
| US Implant Solutions, LLC | $667.07 | 2025 | |
| Flower Orthopedics Coporation | $384.70 | 2025 | |
| Polynovo North America LLC | $218.97 | 2025 | Novosorb Btm |
| Globus Medical, INC. | $173.80 | 2025 | Anthem, Autobahn |
| Medtronic, INC. | $125.99 | 2022 | |
| Novus Surgical Solutions LLC | $102.61 | 2022 | |
| Si-Bone, INC. | $91.50 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $70.42 | 2025 | Dvr Anatomic Kickstand |
| Orthalign INC | $53.17 | 2025 | Orthalign Plus |
| Heron Therapeutics, INC. | $46.40 | 2025 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Doyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.